A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Lung Cancer · Breast Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Alabama at Birmingham, Birmingham, Alabama, United States

    Contact: Study coordinator (Aakash Desai) · 919-525-0054
  • University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Gilberto DE LIMA LOPES JUNIOR) · 305-243-1086
  • Local Institution - 0125, Maywood, Illinois, United States

  • Local Institution - 0065, Iowa City, Iowa, United States

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States

    Contact: Study coordinator (Martin Gutierrez) · 551-996-5863
  • Cleveland Clinic, Cleveland, Ohio, United States

    Contact: Study coordinator (Khaled Hassan) · 734-615-2939
  • Local Institution - 0102, Columbus, Ohio, United States

  • Local Institution - 0134, Portland, Oregon, United States

  • Local Institution - 0052, Portland, Oregon, United States

  • Local Institution - 0090, Portland, Oregon, United States

  • Local Institution - 0014, Pittsburgh, Pennsylvania, United States

  • University of Tennessee Medical Center, Knoxville, Tennessee, United States

    Contact: Study coordinator (Sarah Jenkins) · 865-305-8780
  • NEXT Oncology - Irving, Irving, Texas, United States

    Contact: Study coordinator (Michael Song) · 210-580-9500
  • Swedish Medical Center, Seattle, Washington, United States

    Contact: Study coordinator (Siddhartha Devarakonda) · 206-386-2457
  • Liverpool Hospital, Liverpool, New South Wales, Australia

    Contact: Study coordinator (Abhijit Pal) · 61287389744
  • Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

    Contact: Study coordinator (Wen Xu) · +61731766577
  • Local Institution - 0108, East Melbourne, Victoria, Australia

  • Local Institution - 0101, Subiaco, Western Australia, Australia

  • Cross Cancer Institute, Edmonton, Alberta, Canada

    Contact: Study coordinator (Quincy Chu) · 7804328248
  • Local Institution - 0064, Newmarket, Ontario, Canada

  • Local Institution - 0023, Ottawa, Ontario, Canada

  • The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada

    Contact: Study coordinator (Scott Laurie) · 6137377700
  • Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada

    Contact: Study coordinator (Marie Florescu) · 5148908000
  • Jewish General Hospital, Montreal, Quebec, Canada

    Contact: Study coordinator (Jennifer Friedmann) · 514340822224915
  • Local Institution - 0105, Valdivia, Los Ríos Region, Chile

  • Local Institution - 0048, Santiago, Santiago Metropolitan, Chile

  • Local Institution - 0049, Santiago, Santiago Metropolitan, Chile

  • Local Institution - 0047, Santiago, Santiago Metropolitan, Chile

  • Local Institution - 0107, Viña del Mar, Valparaiso, Chile

  • Local Institution - 0077, Nice, Alpes-Maritimes, France

  • Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux, Aquitaine, France

    Contact: Study coordinator (Sophie Cousin) · 33556333229
  • Centre Leon Berard, Lyon, Auvergne-Rhône-Alpes, France

    Contact: Study coordinator (Aurelie Swalduz) · +33469856041
  • Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone, Marseille, Bouches-du-Rhône, France

    Contact: Study coordinator (Laurent Greillier) · 33491324400
  • Local Institution - 0076, Caen, Calvados, France

  • Hôpital Arnaud de Villeneuve - CHU Montpellier, Montpellier, Hérault, France

    Contact: Study coordinator (Benoit Roch) · +33467330759
  • Gustave Roussy, Villejuif, Val-de-Marne, France

    Contact: Study coordinator (David Planchard) · 33142114211
  • Institut Curie, Paris, France

    Contact: Study coordinator (nicolas girard) · +33624456290
  • Hôpital Tenon, Paris, France

    Contact: Study coordinator (Jacques Cadranel) · 33156016531
  • Cro-Irccs, Aviano, Friuli Venezia Giulia, Italy

    Contact: Study coordinator (Alessandra Bearz) · 390434659294
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardy, Italy

    Contact: Study coordinator (Giuseppe Lo Russo) · 390223903829
  • Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia, Candiolo, Torino, Italy

    Contact: Study coordinator (Vanesa Gregorc) · 390119933250
  • Azienda Ospedaliera Universitaria Careggi, Florence, Tuscany, Italy

    Contact: Study coordinator (Lorenzo Antonuzzo) · 00390557947298
  • Local Institution - 0110, Ancona, Italy

  • Local Institution - 0093, Milan, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore, Roma, Italy

    Contact: Study coordinator (Gennaro Daniele) · +390630153446
  • Leids Universitair Medisch Centrum, Leiden, South Holland, Netherlands

    Contact: Study coordinator (Egbert Smit) · 31715262950
  • Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI AVL), Amsterdam, Netherlands

    Contact: Study coordinator (Gerrina Ruiter) · 0031205122958
  • CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [La Coruña], Spain

    Contact: Study coordinator (Jorge Garcia Gonzalez)
  • Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], Spain

    Contact: Study coordinator (Enriqueta Felip Font) · 34932746077
  • Institut Català d'Oncologia - L'Hospitalet, Hospitalet, Barcelona [Barcelona], Spain

    Contact: Study coordinator (NOELIA Vilarino Quintela) · 34932275402
  • Local Institution - 0059, Barcelona, Catalunya [Cataluña], Spain

  • Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad de, Spain

    Contact: Study coordinator (Luis Paz-Ares Rodriguez) · 0034913908922
  • Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad de, Spain

    Contact: Study coordinator (Mariano Provencio Pulla) · 34911917759
  • Local Institution - 0118, Valencia, Valenciana, Comunitat, Spain

  • Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

    Contact: Study coordinator (Ester García Lorenzo)
  • Local Institution - 0127, Madrid, Spain

  • Hospital Universitario HM Sanchinarro, Madrid, Spain

    Contact: Study coordinator (Ramon Yarza Barrio) · 349155048002805
  • H.R.U Málaga - Hospital General, Málaga, Spain

    Contact: Study coordinator (Manuel Cobo-Dols) · 00349422033350000
  • Local Institution - 0112, Seville, Spain

  • Hospital Universitari i Politecnic La Fe, Valencia, Spain

    Contact: Study coordinator (Oscar Juan Vidal) · 34961245877
  • Royal Free Hospital, London, England, United Kingdom

    Contact: Study coordinator (Alexa Childs) · 442077040500
  • Local Institution - 0021, Glasgow, Glasgow City, United Kingdom

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, West Midlands, United Kingdom

    Contact: Study coordinator (Gary Middleton) · 441214158237
  • Local Institution - 0001, Newcastle upon Tyne, United Kingdom

מובילי המחקר
  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb